Cargando…
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
Autores principales: | Zang, Jinkai, Gu, Chenjian, Zhou, Bingjie, Zhang, Chao, Yang, Yong, Xu, Shiqi, Bai, Lulu, Zhang, Rong, Deng, Qiang, Yuan, Zhenghong, Tang, Hong, Qu, Di, Lavillette, Dimitri, Xie, Youhua, Huang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471522/ https://www.ncbi.nlm.nih.gov/pubmed/32901211 http://dx.doi.org/10.1038/s41421-020-00199-1 |
Ejemplares similares
-
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
por: Xu, Shiqi, et al.
Publicado: (2022) -
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022) -
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
por: He, Xiangchuan, et al.
Publicado: (2021) -
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
por: Gavor, Edem, et al.
Publicado: (2020) -
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
por: Jiang, Wen, et al.
Publicado: (2021)